|
CN110483470A
|
|
A method of preparing hydrochloride landiolol
|
|
CN109810073A
|
|
4- arylthiazole derivative and its pharmaceutical composition
|
|
CN109528674A
|
|
A kind of Eliquis pharmaceutical composition and preparation method thereof containing hydrophilic version
|
|
CN107056860A
|
|
2- diazanyl adenosines and preparation method thereof
|
|
CN106706796A
|
|
Method for detecting optical isomer of key intermediate 1R-trifluoroacetate of bortezomib by HPLC (high performance liquid chromatography)
|
|
CN102579370A
|
|
Drug combination containing levocarnitine derivatives and preparation method of drug combination
|
|
CN102557972A
|
|
Polycrystal substance of acetyl chloride levocarnitine
|
|
CN102232930A
|
|
Landiolol hydrochloride pharmaceutical compositions and preparation methods thereof
|
|
CN102106846A
|
|
Levogyration esmolol hydrochloride medicinal compositions and preparation method thereof
|
|
CN101928259A
|
|
2-arylthiazole derivative and medicament composition thereof
|
|
CN101891636A
|
|
Novel method for preparing esmolol hydrochloride optical isomer
|
|
CN101881756A
|
|
Method for analyzing and separating Febuxostat and intermediates thereof by high performance liquid chromatography
|
|
CN101858892A
|
|
Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography
|
